Decane

Decane

SCHEMBL1668245

C(OCC1CO1)C1CO1.CCCCCCCCCC

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.80
TDP1 Q9NUW8 1/20 0.80
SMN1; SMN2 Q16637 1/20 0.72
TSHR P16473 2/20 0.56
MAPK1 P28482 1/20 0.50
EPHX1 P07099 1/20 0.45
ENPP2 Q13822 1/20 0.44
LPAR2 Q9HBW0 1/20 0.44
SPHK1 Q9NYA1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8578760 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Hexadecane SCHEMBL2069576 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
SCHEMBL7775059 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Nonane SCHEMBL3129159 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Tetradecane SCHEMBL22157 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Undecane SCHEMBL2029986 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Pentadecane SCHEMBL7773050 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Heptane SCHEMBL7774936 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Tridecane SCHEMBL2035596 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1
Octane SCHEMBL236934 1.00 ALDH1A1 (0.80) ALDH1A1TDP1SMN1; SMN2TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8821624-B2 Ceramic extrusion molding composition and binder SHIN-ETSU CHEMICAL CO., LTD. (JP) 2014-09-02 US claimed
EP-2468467-B1 Ceramic extrusion molding composition and binder SHINETSU CHEMICAL CO (JP) 2013-09-18 EP claimed
CN-101896570-A Method, obtainable isocyanate-group-terminated poly-adduct and uses thereof thus of the polymkeric substance of preparation hydroxyl-functional SIKA TECHNOLOGY AG 2010-11-24 CN claimed
EP-1778759-B1 PHOTOSENSITIVE DIELECTRIC RESIN COMPOSITIONS AND THEIR USES PROMERUS LLC (US) 2008-11-12 EP claimed
US-5958869-A BASIC AMINO-ACID DERIVATIVES OR SALTS THEREOF OBTAINED BY REACTING GLYCIDYL ETHERS WITH BASIC AMINO ACIDS OR SALTS THEREOF AJINOMOTO CO., INC. (JP) 1999-09-28 US claimed
US-20260022104-A1 AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-01-22 US disclosed
US-20260008901-A1 AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2026-01-08 US disclosed
US-12404363-B2 Epoxy resin composition and cured product of same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-09-02 US disclosed
EP-4592280-A1 AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-07-30 EP disclosed
EP-4592281-A1 AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-07-30 EP disclosed
EP-3623500-B1 PRIMARY AMINE-CONTAINING POLYMERS USEFUL AS SCALE INHIBITORS CYTEC IND INC (US) 2025-06-04 EP disclosed
US-20250171581-A1 EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2025-05-29 US disclosed
US-5447647-A Comprise carboxylic esters as base oil and an epoxy compound additive; compatible with new hydrogen containing halocarbons; nonhydrolyzing NIPPON OIL CO., LTD. (JP) 1995-09-05 US disclosed
EP-0302007-B1 HYDROXYETHER-CARBOXYLIC ACIDS AND LACTONES THEREOF, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS CORROSION INHIBITORS CIBA-GEIGY AG (CH) 1992-05-13 EP disclosed
US-5108634-A LUBRICATING OIL COMPOSITION COMPRISING A SPECIFIED BASE OIL AND AN ALKYL SUBSTITUTED PHENOL IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-04-28 US disclosed
US-5055230-A Coating a metal surface with an aqueous system CIBA-GEIGY CORPORATION (US) 1991-10-08 US disclosed
EP-0302007-A1 Hydroxyether-carboxylic acids and lactones thereof, process for their production and their use as corrosion inhibitors CIBA-GEIGY AG (CH) 1989-02-01 EP disclosed
US-4252708-A MICROCAPSULES CONTAINING LATENT LEWIS ACID-GLYCEROL COMPLEX CATALYST MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1981-02-24 US disclosed
US-4237252-A RUPTURABLE MICROCAPSULES OF A CURABLE STORAGE STABLE COMPOSITION INCLUDING A LATENT POLYMERIZATION CATALYST AND A LEWIS BASE SCAVENGER STABILIZER MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-12-02 US disclosed
US-4225460-A Latent Lewis acid catalyst system and process MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1980-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022104-A1 AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME ASH2L, PRMT1, RER1 ALDH1A1 982/4885TDP1 3994/4885SMN1; SMN2 2005/4885
US-20260008901-A1 AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME PRMT1, SRM, BCAT2 ALDH1A1 514/4885TDP1 2574/4885SMN1; SMN2 1870/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.